ChatGPT Better Than Physicians in Responding to Patient's Queries

+ChatGPT Better Than Physicians in Responding to Patient's Queries: Report+

Imagine you're feeling under the weather, but you're not sure if you should see a doctor. Maybe it's just a cold, but maybe it's something more serious. You don't want to waste your time or money going to see a doctor if it's unnecessary, but you also don't want to ignore a serious problem.

This is where ChatGPT comes into play. ChatGPT is an artificial intelligence (AI)-powered chatbot that can help answer your health-related questions. The chatbot can ask you questions about your symptoms and give you advice on what to do next. ChatGPT is available 24/7 and doesn't require an appointment or insurance.

Real-life examples of ChatGPT's success abound. For instance, in one study conducted by the University of California San Francisco, patients were asked to use ChatGPT to ask medical questions. The responses they received from ChatGPT were compared to those given by physicians. The study found that ChatGPT was able to provide better and more accurate responses than the physicians in many cases.

Similarly, many people have turned to ChatGPT during the COVID-19 pandemic. With so much conflicting information and advice about COVID-19 available, it can be hard to know what to trust. However, ChatGPT has been proven to provide reliable information about the virus and how to stay safe.

Two of the main companies behind ChatGPT are OpenAI and Microsoft. OpenAI is a research lab that aims to develop AI in a safe and beneficial way, while Microsoft is a technology company that has been working with OpenAI to develop ChatGPT.

While ChatGPT has many benefits, it's important to note that it's not a substitute for seeing a physician in person. ChatGPT can only provide general advice and cannot diagnose or treat specific medical conditions. Therefore, it's important to use ChatGPT as a starting point, but to seek real medical attention if necessary.

Akash Mittal Tech Article

Share on Twitter
Share on LinkedIn